RxDoctor Payments Data

David Minion, MD

Vascular Surgery · Lexington, KYNPI 1417048711

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,666 of the $24,801 with a category attached, or 67.2%. Medical Device Business Services, Inc. accounts for 76.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $9,519 and has fallen 93.3% since, to $636 in 2025.

$24,801in general payments, 2019–2025

Across 64 payments — averaging $387.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$19K
  • W. L. Gore & Associates, Inc.$4K
  • Cook Medical LLC$1K
  • Organogenesis Inc.$369
  • Endologix LLC$257
  • Bolton Medical Inc$174
  • plus $316 from 5 others
$6,395in research payments, 2019–2025

Across 11 payments — averaging $581.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$6K

What the payments were for

  • Consulting fees$16,66667%
  • Travel & lodging$4,44218%
  • Food & beverage$3,69315%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,801 in reported general payments places this provider in the 80th percentile of 72 vascular surgery providers in Kentucky.

See all vascular surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$64,513
Medicare patients
392
Services billed
669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate18$64

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →